Trials that use: Logistic regression
New to this method? Read the tutorial →
4,487 results
- Foot and Ankle Clinic Application for Liposomal Related Anesthetic: Complete Statistical AnalysisIndependent statistical analysis of Foot and Ankle Clinic Application for Liposomal Related Anesthetic: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02586077).
- Foot Neuromodulation for Nocturnal Enuresis: Complete Statistical AnalysisIndependent statistical analysis of Foot Neuromodulation for Nocturnal Enuresis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02315560).
- Forced-air Warming in Endovascular Surgery: Testing Effectiveness of Two Different Blanket Models: Complete Statistical AnalysisIndependent statistical analysis of Forced-air Warming in Endovascular Surgery: Testing Effectiveness of Two Different Blanket Models: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- FORESTIndependent statistical analysis of Family History and Cancer Risk Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05079334).
- ForTeIndependent statistical analysis of Building Resiliency Among Caregivers of Curvivors and Metavivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05702723).
- FOSAMAX PLUS and FOSAMAX PLUS D Re-examination Study (0217A-267): Complete Statistical AnalysisIndependent statistical analysis of FOSAMAX PLUS and FOSAMAX PLUS D Re-examination Study (0217A-267): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01065779).
- FOXIndependent statistical analysis of Performance of DAILIES TOTAL1 Daily Disposable Contact Lenses in Habitual Soft Lens Wearers Who Report Substantial Digital Device Use: primary endpoint results, effect estimate with confidence interval, sample-size…
- Fractionated Stereotactic Radiosurgery for Large Brain Metastases: Complete Statistical AnalysisIndependent statistical analysis of Fractionated Stereotactic Radiosurgery for Large Brain Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02054689).
- Fracture Risk With Thiazolidinediones: Complete Statistical AnalysisIndependent statistical analysis of Fracture Risk With Thiazolidinediones: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01055223).
- FREEDOMS IIIndependent statistical analysis of Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- FREESIAIndependent statistical analysis of Effects of JNJ-53718678 in Adult and Adolescent Participants Who Had a Hematopoietic Stem Cell Transplantation and Who Are Infected With Respiratory Syncytial Virus (RSV): primary endpoint results, effect…
- FRESHIndependent statistical analysis of FimasaRtan-basEd BP Targets After Drug SwitcHing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03649646).
- Frespaciguat (MK-5475) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD) (MK-5475-006): Complete Statistical AnalysisIndependent statistical analysis of Frespaciguat (MK-5475) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD) (MK-5475-006): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- From Innovation to Solutions: Childhood Influenza Vaccination Planning: Complete Statistical AnalysisIndependent statistical analysis of From Innovation to Solutions: Childhood Influenza Vaccination Planning: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01664793).
- Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease: Complete Statistical AnalysisIndependent statistical analysis of Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- FRONTIERIndependent statistical analysis of Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- FROZEN-AFIndependent statistical analysis of Boston Scientific's Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Fucidin® Cream in the Treatment of Impetigo: Complete Statistical AnalysisIndependent statistical analysis of Fucidin® Cream in the Treatment of Impetigo: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00986856).
- Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole: Complete Statistical AnalysisIndependent statistical analysis of Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00543127).
- Functional Imaging of Tremor Circuits and Mechanisms of Treatment Response: Complete Statistical AnalysisIndependent statistical analysis of Functional Imaging of Tremor Circuits and Mechanisms of Treatment Response: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02495883).
- Functional MRI Use in Prostate Radiation Treatment Planning: Complete Statistical AnalysisIndependent statistical analysis of Functional MRI Use in Prostate Radiation Treatment Planning: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01985932).
- Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT): Complete Statistical AnalysisIndependent statistical analysis of Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- FX-322 in Sensorineural Hearing Loss: Complete Statistical AnalysisIndependent statistical analysis of FX-322 in Sensorineural Hearing Loss: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03616223).
- FX-LEARNIndependent statistical analysis of AFQ056 for Language Learning in Children With FXS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02920892).
- G-BMTIndependent statistical analysis of Buprenorphine Group Medical Visits in Primary Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02526212).
- G-MINORIndependent statistical analysis of Genomics in Michigan Impacting Observation or Radiation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02783950).
- G-Pen™ for Hypoglycemia Rescue in T1D Patients: Complete Statistical AnalysisIndependent statistical analysis of G-Pen™ for Hypoglycemia Rescue in T1D Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02423980).
- G2YMIIndependent statistical analysis of Getting to Yes, Michigan! (G2YMI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05096260).
- Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD): Complete Statistical AnalysisIndependent statistical analysis of Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01138124).
- Gabapentin for Insomnia Symptoms and Nighttime Vasomotor Symptoms (VMS) in Peri- and Postmenopausal Women: Complete Statistical AnalysisIndependent statistical analysis of Gabapentin for Insomnia Symptoms and Nighttime Vasomotor Symptoms (VMS) in Peri- and Postmenopausal Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00880191).
- Gabapentin to Improve Patient Tolerance in Endoscopic Retrograde Cholangiopancreatography (ERCP): Complete Statistical AnalysisIndependent statistical analysis of Gabapentin to Improve Patient Tolerance in Endoscopic Retrograde Cholangiopancreatography (ERCP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01143766).
- GAINIndependent statistical analysis of Improving HIV Diagnosis, Linkage to Care, and Prevention Services With HIV Point-of-Care Nucleic Acid Tests: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- GAINS-2Independent statistical analysis of A Brief Cognitive Task Intervention for NHS Staff Affected by COVID-19 Trauma (GAINS-2 Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- GALAXYIndependent statistical analysis of Long-term Evaluation of the Linox Family ICD Leads Registry (GALAXY): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00836589).
- Gallium-68 PSMA-11 PET Imaging in Prostate Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Gallium-68 PSMA-11 PET Imaging in Prostate Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03803475).
- GAM 10-06Independent statistical analysis of Non-Interventional Study on the Tolerability and Efficacy of IVIG: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02303093).
- GAMES-PILOTIndependent statistical analysis of Glyburide Advantage in Malignant Edema and Stroke Pilot: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01268683).
- GAMINIIIndependent statistical analysis of Gut and Azithromycin Mechanisms in Infants and Children II: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04315272).
- GANfort® in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Are Insufficiently Responsive to Monotherapy: Complete Statistical AnalysisIndependent statistical analysis of GANfort® in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Are Insufficiently Responsive to Monotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Gardasil Vaccination in Post Stem Cell Transplant Patients: Complete Statistical AnalysisIndependent statistical analysis of Gardasil Vaccination in Post Stem Cell Transplant Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01092195).
- GARGLESIndependent statistical analysis of Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Gastric Ultrasound in Tube Fed Intubated Patients: Complete Statistical AnalysisIndependent statistical analysis of Gastric Ultrasound in Tube Fed Intubated Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04612348).
- Gastric Ultrasound: Complete Statistical AnalysisIndependent statistical analysis of Gastric Ultrasound: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04127331).
- Gastric Volumes by US in Term Parturients Undergoing CS With and Without Metoclopramide: Complete Statistical AnalysisIndependent statistical analysis of Gastric Volumes by US in Term Parturients Undergoing CS With and Without Metoclopramide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- GATEWAYIndependent statistical analysis of A Phase I/II Study of VTX-801 in Adult Patients With Wilson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- GBT021601-022: A Study of GBT021601 in Participants With Sickle Cell Disease (SCD): Complete Statistical AnalysisIndependent statistical analysis of GBT021601-022: A Study of GBT021601 in Participants With Sickle Cell Disease (SCD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- GDX-44-016Independent statistical analysis of Performance of Elucirem in DSC-MRI Perfusion of Brain Gliomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06057168).
- Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer: Complete Statistical AnalysisIndependent statistical analysis of Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00388154).